Infectious Disease Research Funding: Addition to Primary List

NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional)

National Institutes of Health (NIH)

5-Feb-25

NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)

National Eye Institute (NEI)

National Institutes of Health (NIH)

16-Feb-25

$275,000USD

Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institutes of Health (NIH)

19-Feb-25

LCRF|Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations

Lung Cancer Research Foundation (LCRF)

3-Mar-25

$500,000USD

Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

10-Mar-25

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institutes of Health (NIH)

13-Mar-25

Lesbian Health Fund (LHF)

GLMA: Health Professionals Advancing LGBT Equality

15-Mar-25

$10,000USD

Career Development Awards (CDA)

Melanoma Research Foundation (MRF)

31-Mar-25

$100,000USD

Established Investigator Award (EIA)

Melanoma Research Foundation (MRF)

31-Mar-25

$250,000USD

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institutes of Health (NIH)

7-May-25

$300,000USD

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institutes of Health (NIH)

7-May-25

$275,000USD

Development & Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

7-May-25

Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institutes of Health (NIH)

7-May-25

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

National Institutes of Health (NIH)

7-May-25

$275,000USD

Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)

National Institutes of Health (NIH)

13-Aug-25

Innovations to Prepare for Future Epidemics and Pandemics

Coalition for Epidemic Preparedness Innovations (CEPI)

$5,000,000USD